James Bauersmith

James Bauersmith

Director/Board Member at LANNETT COMPANY, INC.
Health Technology
Consumer Services
Health Services

Profile

Mr. James Bauersmith is a Vice President, Translational Sciences at UPMC Enterprises.
He is on the Board of Directors at Lannett Co., Inc. Mr. Bauersmith was previously employed as a Chief Strategy Officer & General Counsel by Second Science Inc, a SVP Head of Corporate Development & Procurement by Amneal NewCo, Inc., and a SVP, Head of Global Drug Portfolio Strategy by Fresenius SE & Co. KGaA. He also served on the board at Akorn, Inc. He received his undergraduate degree from the University of Notre Dame, a graduate degree from Drexel University and a graduate degree from The Pennsylvania State University.

James Bauersmith active positions

CompaniesPositionStart
LANNETT COMPANY, INC. Director/Board Member -
Corporate Officer/Principal 01/08/2021

Former positions of James Bauersmith

CompaniesPositionEnd
General Counsel 01/10/2021
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2019
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 31/05/2018
AKORN, INC. Director/Board Member -
See the detail of James Bauersmith's experience

Training of James Bauersmith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Consumer Services

Finance

Consumer Non-Durables

Health Technology

  1. Stock Market
  2. Insiders
  3. James Bauersmith
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!